MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

NeoGenomics Inc

Closed

10.05 1.72

Overview

Share price change

24h

Current

Min

9.7

Max

10.13

Key metrics

By Trading Economics

Income

2.4M

-15M

Sales

4.2M

172M

EPS

0.04

Profit margin

-8.909

Employees

2,200

EBITDA

1.9M

3.7M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+66.3% upside

Dividends

By Dow Jones

Next Earnings

29 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-360M

1.2B

Previous open

8.33

Previous close

10.05

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

NeoGenomics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Apr 2025, 15:50 UTC

Acquisitions, Mergers, Takeovers

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One -- Update

23 Apr 2025, 14:29 UTC

Acquisitions, Mergers, Takeovers

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One

16 Apr 2025, 15:17 UTC

Major Market Movers

Janover Shares Drop After Partnership Plans With Crypto Exchange

10 Apr 2025, 15:12 UTC

Major Market Movers

Janover Shares Rise After Company Begins Solana Purchases

24 Apr 2025, 11:49 UTC

Market Talk

Bitcoin Eases After Recent Risk-On Rally -- Market Talk

23 Apr 2025, 15:35 UTC

Acquisitions, Mergers, Takeovers

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One -- Update

23 Apr 2025, 14:14 UTC

Acquisitions, Mergers, Takeovers

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One

23 Apr 2025, 09:17 UTC

Top News

Bitcoin Price Rises Above $94,000 -- WSJ

23 Apr 2025, 09:04 UTC

Top News

Bitcoin Price Rallies. Why Trump, Fed and China Are Boosting the Crypto. -- Barrons.com

23 Apr 2025, 08:37 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23 Apr 2025, 08:37 UTC

Market Talk

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Trade War -- Market Talk

23 Apr 2025, 01:00 UTC

Top News

'I Could Lose It All Tomorrow': The Traders Leaning In to Wild Markets -- WSJ

22 Apr 2025, 13:58 UTC

Market Talk

Fed Independence Concerns Could Lift Bitcoin to Record High -- Market Talk

22 Apr 2025, 08:47 UTC

Market Talk

Bitcoin Rises as Investors Seek Dollar Alternatives -- Market Talk

21 Apr 2025, 14:28 UTC

Top News

Bitcoin Rises. Tariffs, the Dollar, and What Else Is Boosting Crypto Prices. -- Barrons.com

21 Apr 2025, 14:01 UTC

Acquisitions, Mergers, Takeovers

MicroStrategy Stock Is Rising on Latest $556 Million Bitcoin Purchase -- Barrons.com

21 Apr 2025, 09:30 UTC

Top News

Crypto Knocks on the Door of a Banking World That Shut It Out -- WSJ

21 Apr 2025, 09:04 UTC

Top News

Bitcoin and Other Crypto Prices Rise. It's All Linked to Dollar Weakness. -- Barrons.com

17 Apr 2025, 14:03 UTC

Market Talk

ECB's Lagarde Welcomes Review of Stablecoin Regulation -- Market Talk

17 Apr 2025, 14:01 UTC

Market Talk

ECB's Lagarde Highlights Digital Euro Efforts -- Market Talk

17 Apr 2025, 09:48 UTC

Market Talk

Bitcoin Struggles to Rise Meaningfully After Trade News, Powell Remarks -- Market Talk

16 Apr 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16 Apr 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

16 Apr 2025, 16:09 UTC

Market Talk

Crypto Trading Demand Lower Than Expected, Interactive Brokers CEO Says -- Market Talk

15 Apr 2025, 08:33 UTC

Market Talk

Bitcoin Edges Higher Amid Optimism Over Tariff Exemptions -- Market Talk

14 Apr 2025, 15:52 UTC

Acquisitions, Mergers, Takeovers

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

14 Apr 2025, 14:10 UTC

Acquisitions, Mergers, Takeovers

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

14 Apr 2025, 08:41 UTC

Top News

Bitcoin, XRP, Ether Prices Mixed Amid Tariff Turmoil. Watch This Key Crypto Level. -- Barrons.com

10 Apr 2025, 11:37 UTC

Market Talk

Bitcoin Falls After Brief Boost From Tariff Delay -- Market Talk

9 Apr 2025, 10:51 UTC

Market Talk

Bitcoin Struggles to Recover Meaningfully as Tariff Worries Cap Gains -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

66.3% upside

12 Months Forecast

Average 16.78 USD  66.3%

High 19 USD

Low 12 USD

Based on 14 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

10

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

9.56 / 10.44Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.